Agenda

28th November 2019, Manchester

*Programme subject to change

SESSION 1 – BARRIERS TO ADOPTION

08:45 – Delegate Registration, Refreshments, Networking and Exhibition co-hosted with ‘Antibiotic Stewardship in Animal Health & Food Supply Chains’ attendees
Speaker: Doris-Ann Williams MBE, Chief Executive, BIVDA – Confirmed
Speaker: Angela Douglas, CBE, Deputy Chief Scientific Officer – Confirmed
Speaker: Paul Dark, Chair in Critical Care Medicine, Research Professor, The University of Manchester

Chair: Scott Buckler, Conference Director

Panelist: Doris-Ann Williams MBE, Chief Executive, BIVDA

Panelist: Professor Paul Dark , Chair in Critical Care Medicine, Research Professor, The University of Manchester

Panelist: Professor Gail Hayward, Deputy Director of the CH-MIC

Panelist: Stephen Lynn, Business Manager, Academic Health Science Network for the North East and North Cumbria (AHSN NENC)

SESSION 2 – EVALUATING DATA, ECONOMICS AND TECHNOLOGY

The NIHR Community Healthcare MedTech and IVD Co-operative (CH-MIC) supports the generation of robust evidence for the performance of diagnostics in community settings.

The CH-MIC also engages with developers at an early (pre-CE marking) stage to help ensure that new technologies are fit for purpose in the community.

During this short workshop, Professor Gail Hayward, Deputy Director of the CH-MIC, will provide a short overview of the evidence cycle for the comprehensive evaluation of diagnostic tests.

Attendees will then divide into groups with MIC facilitators to discuss the further evaluation (ie what is needed, and how should it best be achieved) of case studies of diagnostic tests at different stages of development.

On conclusion, groups will reconvene to discuss general learnings and will have the opportunity to register their interest with CH-MIC staff for offline discussions around their own diagnostic evidence generation needs.


Speaker: Professor Gail Hayward, Deputy Director of the CH-MIC – Confirmed

In contrary to organised, well documented and controlled inpatient care, patients and healthcare professionals could often feel frustrated from improper, error-prone and not well documented care in the outpatient setting. This often leads to valuable information being lost as soon as patients are discharged from the hospital and commonly results in poor therapy compliance and further hospital re-admissions. A web solution that would ease the process of care coordination in the outpatient setting and effectively reduce poor compliance and care fragmentation is therefore greatly needed.

A wide variety of simple or more complex disease management cases where care coordination is recommended can be covered by using interoperable, patient-centric web application Vitaly Managed Care (which enables multidisciplinary teams of professionals to collaborate and facilitate coordinated care for improved therapy outcomes).

The distinctive value of Vitaly Managed Care will be presented on a recent NHS project »WelLPRES« implemented in Lancashire and South Cumbria region. The project aim is to digitise the outdated analogue approach of 5-year cancer recovery programmes through a holistically designed tool that allows for personalised and coordinated care of the patients in recovery from breast, prostate and colorectal cancer by supporting care professionals with a standardised approach to core care delivery through the digital platform, allowing personalisation based on clinical judgement and patient-reported needs.

Speaker: Zan Virtnik, Implementation Specialist, Parsek

SESSION 3 – DIAGNOSTICS IN ACTION

Speaker: Ms Emma Kelly, Community Pharmacist, Northern Pharmacies Ltd – Confirmed
Speaker: Timo Jauhiainen , Sales Director Europe, Ginolis Ltd
Speaker: Cheryl Way, National Pharmacy and Medicines Management Lead, NHS Wales Informatics Service – Confirmed

Influenza point of care testing in Mid Yorkshire Hospitals NHS Trust was introduced in 2017/18.

Previous testing involved transporting samples to a neighbouring teaching hospital.

Following its introduction, those patients with a positive flu test received two fewer days of antibiotics, from 6 to 4 days (median).

A further reduction to 2 days of antibiotics was demonstrated in the second year of point of care testing. Improvements were also seen in infection control, as patients could be isolated more quickly.

The initiative demonstrates the value of influenza point of care testing methods.


Speaker: Christine Cruise, Head of Infection Control, Mid Yorkshire Hospitals NHS Trust – Confirmed

Speaker: Dr Anita Sharma, Clinical Lead, Oldham GP Federation – Confirmed
Speaker: Geraldine Conlon, Research/Antimicrobial Pharmacist, MOIC